GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Total Assets

Tianda Pharmaceuticals (HKSE:00455) Total Assets : HK$917.3 Mil (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Total Assets?

Tianda Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was HK$917.3 Mil.

Warning Sign:

If a company builds assets at 9.2% a year, faster than its revenue growth rate of 5.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Tianda Pharmaceuticals's average Total Assets Growth Rate was -7.40% per year. During the past 3 years, the average Total Assets Growth Rate was 6.40% per year. During the past 5 years, the average Total Assets Growth Rate was 9.20% per year. During the past 10 years, the average Total Assets Growth Rate was 4.00% per year.

During the past 13 years, Tianda Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 57.00%. The lowest was -12.70%. And the median was 6.95%.

Total Assets is connected with ROA %. Tianda Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 was -4.25%. Total Assets is also linked to Revenue through Asset Turnover. Tianda Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.24.


Tianda Pharmaceuticals Total Assets Historical Data

The historical data trend for Tianda Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Total Assets Chart

Tianda Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 996.77 933.12 1,133.46 1,164.15 917.29

Tianda Pharmaceuticals Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,125.21 1,164.15 1,006.05 967.52 917.29

Tianda Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tianda Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=591.941+325.35
=917.3

Tianda Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=591.941+325.35
=917.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianda Pharmaceuticals  (HKSE:00455) Total Assets Explanation

Total Assets is connected with ROA %.

Tianda Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-40.056/( (967.516+917.291)/ 2 )
=-40.056/942.4035
=-4.25 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tianda Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=228.605/( (967.516+917.291)/ 2 )
=228.605/942.4035
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tianda Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianda Pharmaceuticals (HKSE:00455) Business Description

Traded in Other Exchanges
N/A
Address
CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG
Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.
Executives
Tianda Group Limited 2101 Beneficial owner
Fang Wen Quan 2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines